Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fiel… Read more
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) - Total Liabilities
Latest total liabilities as of September 2025: CN¥676.78 Million CNY
Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has total liabilities worth CN¥676.78 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Total Liabilities Trend (1992–2024)
This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Competitors by Total Liabilities
The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lootom Telcovideo Network Wuxi Co Ltd
SHE:300555
|
China | CN¥70.69 Million |
|
Dharma Satya Nusantara Ptdsn
JK:DSNG
|
Indonesia | Rp6.99 Trillion |
|
Refrigeration Electrical Engineering Corp
VN:REE
|
Vietnam | ₫15.28 Trillion |
|
Tianjin Realty Development Group Co Ltd
SHG:600322
|
China | CN¥13.01 Billion |
|
First of Long Island Corp
NASDAQ:FLIC
|
USA | $3.69 Billion |
|
Dodla Dairy Limited
NSE:DODLA
|
India | ₹4.01 Billion |
|
Magnera Corp placeholder
NYSE:MAGN
|
USA | $2.92 Billion |
|
Shenzhen MinDe Electronics Technology Ltd
SHE:300656
|
China | CN¥1.28 Billion |
Liability Composition Analysis (1992–2024)
This chart breaks down Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1992–2024)
The table below shows the annual total liabilities of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1992 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥689.01 Million | -22.48% |
| 2023-12-31 | CN¥888.77 Million | -11.82% |
| 2022-12-31 | CN¥1.01 Billion | +33.24% |
| 2021-12-31 | CN¥756.45 Million | -1.79% |
| 2020-12-31 | CN¥770.28 Million | -13.90% |
| 2019-12-31 | CN¥894.60 Million | +69.51% |
| 2018-12-31 | CN¥527.74 Million | -6.65% |
| 2017-12-31 | CN¥565.34 Million | -0.39% |
| 2016-12-31 | CN¥567.56 Million | +47.43% |
| 2015-12-31 | CN¥384.98 Million | +50.62% |
| 2014-12-31 | CN¥255.60 Million | +39.35% |
| 2013-12-31 | CN¥183.42 Million | +654.66% |
| 2012-12-31 | CN¥24.31 Million | -23.02% |
| 2011-12-31 | CN¥31.57 Million | +10.85% |
| 2010-12-31 | CN¥28.48 Million | -53.01% |
| 2009-12-31 | CN¥60.61 Million | +14.26% |
| 2008-12-31 | CN¥53.04 Million | -41.21% |
| 2007-12-31 | CN¥90.23 Million | -14.22% |
| 2006-12-31 | CN¥105.19 Million | -4.09% |
| 2005-12-31 | CN¥109.67 Million | -40.71% |
| 2004-12-31 | CN¥184.98 Million | +32.17% |
| 2003-12-31 | CN¥139.96 Million | -2.39% |
| 2002-12-31 | CN¥143.38 Million | -8.76% |
| 2001-12-31 | CN¥157.14 Million | -7.00% |
| 2000-12-31 | CN¥168.97 Million | +13.06% |
| 1999-12-31 | CN¥149.46 Million | -61.11% |
| 1998-12-31 | CN¥384.28 Million | +80.69% |
| 1997-12-31 | CN¥212.67 Million | +26.19% |
| 1996-12-31 | CN¥168.53 Million | -0.56% |
| 1995-12-31 | CN¥169.48 Million | +7.14% |
| 1994-12-31 | CN¥158.19 Million | +51.64% |
| 1993-12-31 | CN¥104.32 Million | +23.97% |
| 1992-12-31 | CN¥84.15 Million | -- |